Detalhe da pesquisa
1.
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Breast Cancer Res Treat
; 191(2): 327-333, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34783927
2.
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Ann Surg Oncol
; 27(3): 765-771, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31907749
3.
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Breast Cancer Res Treat
; 176(2): 377-386, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31041683
4.
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.
Mod Pathol
; 31(4): 607-615, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29271415
5.
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.
Blood
; 126(12): 1407-14, 2015 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-26239087
6.
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study.
Breast Cancer Res Treat
; 156(1): 81-9, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26909792
7.
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
Breast Cancer Res
; 16(2): R38, 2014 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24725534
8.
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer.
Breast Cancer Res
; 15(1): R11, 2013 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-23391338
9.
Molecular monitoring of minimal residual disease in the peripheral blood of patients with multiple myeloma.
Biol Blood Marrow Transplant
; 19(7): 1109-15, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23644045
10.
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Breast Cancer Res
; 14(6): R145, 2012 Nov 12.
Artigo
Inglês
| MEDLINE | ID: mdl-23146280
11.
The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter.
Biol Blood Marrow Transplant
; 18(3): 423-431.e3, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21745451
12.
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
J Transl Med
; 10: 10, 2012 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-22240029
13.
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test.
BMC Cancer
; 12: 456, 2012 Oct 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23039280
14.
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer.
Clin Cancer Res
; 28(20): 4435-4443, 2022 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36043530
15.
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
Biomark Med
; 16(6): 449-459, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35321552
16.
Prognostic utility of ß-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Breast Cancer Res Treat
; 127(1): 179-93, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21390496
17.
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
J Clin Oncol
; 39(2): 126-135, 2021 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33108242
18.
Clozapine mobilizes CD34+ hematopoietic stem and progenitor cells and increases plasma concentration of interleukin 6 in patients with schizophrenia.
J Clin Psychopharmacol
; 30(5): 591-5, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20814329
19.
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.
Clin Cancer Res
; 26(17): 4682-4687, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32561662
20.
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer
; 134: 99-106, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32502940